RF, P., B, C., WJ, V., & S, H. (2018). Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach. Dove Medical Press.
Cita Chicago Style (17a ed.)RF, Pollock, Chubb B, Valentine WJ, y Heller S. Evaluating the Cost-effectiveness of Insulin Detemir Versus Neutral Protamine Hagedorn Insulin in Patients with Type 1 or Type 2 Diabetes in the UK Using a Short-term Modeling Approach. Dove Medical Press, 2018.
Cita MLA (8a ed.)RF, Pollock, et al. Evaluating the Cost-effectiveness of Insulin Detemir Versus Neutral Protamine Hagedorn Insulin in Patients with Type 1 or Type 2 Diabetes in the UK Using a Short-term Modeling Approach. Dove Medical Press, 2018.